000 01061 a2200301 4500
005 20250517121829.0
264 0 _c20170622
008 201706s 0 0 eng d
022 _a1437-4331
024 7 _a10.1515/cclm-2016-0381
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarcellona, Doris
245 0 0 _aPoint-of-care testing INR: an overview.
_h[electronic resource]
260 _bClinical chemistry and laboratory medicine
_cMay 2017
300 _a800-805 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aCosts and Cost Analysis
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
_xadverse effects
650 0 4 _aPoint-of-Care Testing
_xeconomics
650 0 4 _aSafety
650 0 4 _aTime Factors
700 1 _aFenu, Lara
700 1 _aMarongiu, Francesco
773 0 _tClinical chemistry and laboratory medicine
_gvol. 55
_gno. 6
_gp. 800-805
856 4 0 _uhttps://doi.org/10.1515/cclm-2016-0381
_zAvailable from publisher's website
999 _c26527420
_d26527420